摘要 |
The present invention is directed, inter alia, to methods of utilizing low calcemic vitamin D analogues. Particularly, the present invention is directed to using low calcemic vitamin D analogues to treat neurodegenerative diseases and disorders, to facilitate endogenous production of neurotrophic factors, to inhibit the degradation, dysfunction or loss of neural cells and/or to enhance the phenotype of neural cells or neuronal processes.
|
申请人 |
CARSWELL, SUSAN;DOBRZANSKI, PAWEL;BINDERUP, LISE;BJOERKLING, FREDRIK;MILLER, MATTHEW, S. |
发明人 |
CARSWELL, SUSAN;DOBRZANSKI, PAWEL;BINDERUP, LISE;BJOERKLING, FREDRIK;MILLER, MATTHEW, S. |